Therefore, IBD, specific genotypes (MLH1, MSH2, EPCAM), and advancing age were found to be independent risk factors for neoplasia, indicating that patients with LS who have these risk factors might benefit from more intensive surveillance [24]. This evidence concerns the gene MSH2 and neoplasm.